Evaluation of the Cerebral Edema in Children Having Diabetic Ketoacidosis

Evaluation of the Cerebral Edema With Measurement of Optic Nerve Sheath in Children Having Diabetic Ketoacidosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02937441

Enrollment

Registered

2016-10-18

Start date

2016-08-31

Completion date

2017-06-30

Last updated

2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Edema

Keywords

C10.228.140.187

Brief summary

The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath.

Detailed description

The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath. For that, If patients have Fluid treatment shall be started in 4 hours in our or other Emergency Care, they will be included our study. If not, they will be out of our study. How we measure; 1. First measurement shall be taken in 4 hours. 2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall be taken for severe diabetic ketoacidosis, 3. Third measurement shall be taken after fluid treatment. 4. Fourth measurement shall be taken at polyclinic control. So, after all measurements will be hand and all data will be analyzed with statistical program. After that all outcome will be discussed and compared with patient at normal conditions at their polyclinic visit.

Interventions

OTHERUltrasonic Measurement

How we measure; 1. First measurement shall be taken in 4 hours. 2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall be taken for severe diabetic ketoacidosis, 3. Third measurement shall be taken after fluid treatment. 4. Fourth measurement shall be taken at patients polyclinic control.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to 18 Years

Healthy volunteers

Inclusion criteria

Fluid treatment shall be started in 4 hours in our or other Emergency Care

Exclusion criteria

Fluid treatment was started over four hours in other Emergency Care

Design outcomes

Primary

Measure	Time frame	Description
Optic Nerve Sheath diameters will be measured from 3 mm back of globe.	March 2017	Optic Nerve Sheath diameters will be measured in Children Having Diabetic Ketoacidosis and compared with normal conditions at polyclinic.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026